<DOC>
	<DOC>NCT02050737</DOC>
	<brief_summary>This is an exploratory, translational, non-interventional and multi-centre clinical study.</brief_summary>
	<brief_title>Plasma Biomarkers C-RAC, ICORG 12-27, V1</brief_title>
	<detailed_description>Cohort A will consist of 100 CRAC patients with stage II/III resectable disease due for adjuvant chemotherapy. Cohort B will consist of 30 patients with stage II resectable disease for observation only. Both cohorts will have a follow up period of up to 2 years, post chemotherapy for cohort A and post resection for cohort B.</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Patient must be able to give written informed consent Histologically or cytologically confirmed CRAC Cohort A: colorectal cancer patients with stage II/III resectable disease due for adjuvant chemotherapy OR Cohort B: colorectal cancer patients with stage II resectable disease for observation only Age â‰¥ 18 years Treatment with curative intent Eastern Cooperative Oncology Group (ECOG) Performance status 0 2 Presence of a medical or psychiatric condition, which, in the opinion of the investigator, would potentially pose a risk to the patient when participating in this trial Evidence of a metastatic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Curative resection</keyword>
	<keyword>Adjuvant chemotherapy</keyword>
</DOC>